Efficacy and Safety of OPN-375 186 ug Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps
- Study HIC#:2000023985
- Last Updated:04/21/2023
To evaluate the efficacy of intranasal administration of OPN-375 186 μg twice a day (BID) versus placebo in adolescents with bilateral nasal polyposis and nasal congestion
- Age12 years - 17 years
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Lina McKinney
- Phone Number: 1-203-737-2168
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
To evaluate the efficacy of intranasal administration of OPN-375 186 ?g twice a day (BID) versus placebo in adolescents with bilateral nasal polyposis and nasal congestion using the co-primary endpoints:
1) reduction of nasal congestion/obstruction symptoms at the end of Week 4 measured by the 7-day average instantaneous morning (AM) diary symptom scores (ADS7-IA); and
2) reduction in total polyp grade (sum of scores from both nasal cavities) at Week 16 as determined by a nasal polyp grading scale score measured using a 0 to 6 point severity grading scale (with 0 to 3 points per nostril).
Eligibility Criteria
Eligibility criteria
Male or female subjects aged 12 to 17 years, inclusive
Must have bilateral nasal polyposis
Must report at least mild symptoms of nasal congestion/obstruction
